Digoxin |
Digitek; Lanoxicaps; Lanoxin |
Digoxin Systematic (IUPAC) name 4-[(3S,5R,8R,9S,10S,12R,13S,14S)-3- [(2S,4S,5R,6R)-5-[(2S,4S,5R,6R)-5- [(2S,4S,5R,6R)-4,5-dihydroxy-6-methyl- oxan-2-yl]oxy-4-hydroxy-6-methyl-oxan- 2-yl]oxy-4-hydroxy-6-methyl-oxan-2-yl] oxy-12,14-dihydroxy-10,13-dimethyl-1, 2,3,4,5,6,7,8,9,11,12,15,16,17-tetra decahydrocyclopenta[a]phenanthren- 17-yl]-5H-furan-2-one Identifiers CAS number C01AA05 ATC code C01AA02 C01AA05 C01AA08 PubChem 30322 DrugBank APRD00098 Chemical data Formula ...
Wikipedia - [full article]
Digoxin Clinical Trials
- Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
ClinicalTrials.gov Identifier: NCT00006330 - Completed
Heart Diseases
- Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin
ClinicalTrials.gov Identifier: NCT00563732 - Not yet recruiting
Alzheimer Disease
- Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00281021 - Recruiting
Carcinoma, Non-Small Cell Lung
- Antibodies to Digoxin for Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00550576 - Recruiting
Bipolar Disorder
- Efficacy Study of Digibind for Treatment of Severe Preeclampsia
ClinicalTrials.gov Identifier: NCT00158743 - Completed
Pre-Eclampsia
- Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
ClinicalTrials.gov Identifier: NCT00000556 - Completed
Arrhythmia; Atrial Fibrillation; Cardiovascular Diseases; Heart Diseases

Not Signed In -


